Alpelisib and its Impurities

Alpelisib, sold under the brand name Piqray, is a medication sold by Novartis and used to treat certain types of breast cancer. It is used together with fulvestrant. Reference standards of Alpelisib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 3 results for Alpelisib Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 01 3000000

Alpelisib

Alpelisib

  • Catalogue No.:PA 01 3000000

  • CAS :

    1217486-61-7

  • Molecular Formula : C19H22F3N5O2S

  • Molecular Weight : 441.47

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 01 3001000

4-Bromo-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine

4-Bromo-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine

  • Catalogue No.:PA 01 3001000

  • CAS :

    1357476-67-5

  • Molecular Formula : C9H9BrF3N

  • Molecular Weight : 268.08

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 01 3001001

Alpelisib Carboxylic Acid

Alpelisib Carboxylic Acid

  • Catalogue No.:PA 01 3001001

  • CAS :

    2715981-74-9

  • Molecular Formula : C19H21F3N4O3S

  • Molecular Weight : 442.46

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
pharmaffiliates